Andrew Emerson serves as Executive Vice President and Chief Financial Officer of IDEXX Laboratories, Inc., a global leader in veterinary diagnostics, software solutions, and water testing technologies. Joining IDEXX in 2004 as Director of Financial Planning and Analysis, Emerson brought extensive expertise from his prior role as a Senior Manager at Deloitte & Touche, where he specialized in audit, advisory, and financial consulting services for life sciences and technology companies. A certified public accountant, he holds both a bachelor's and master's degree in accounting from the University of New Hampshire. Emerson's tenure at IDEXX has been defined by rapid advancement through critical finance leadership positions, including Vice President of Finance, Senior Vice President of Finance, and Senior Vice President and Treasurer, culminating in his appointment as CFO in February 2015. Under his guidance, the company has delivered robust financial performance, including sustained double-digit revenue growth, successful integration of key acquisitions like IDEXX Reference Laboratories expansions, and a strengthened balance sheet that has driven significant shareholder returns. His strategic acumen has supported IDEXX's global scaling, innovation investments, and resilience through economic cycles. As CFO, Emerson oversees comprehensive financial operations, encompassing planning and analysis, reporting, investor relations, treasury, tax strategy, internal audit, and risk management. His leadership has been pivotal in positioning IDEXX for long-term growth, fostering operational efficiency, and enhancing stakeholder value amid the evolving diagnostics landscape.